Delivery Order SPE2DE21D7010-SPE2D626F82K6
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $43,480.80 fixed-price delivery order with economic price adjustment provisions by the Defense Logistics Agency Medical Supply Chain on October 28, 2025, with an ultimate completion date of November 18, 2025. The award is designated as an M5 delivery order issued without set-aside restrictions, indicating competition in an open market procurement. Performance will be...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $9,642.60 by the Defense Logistics Agency Medical Supply Chain on December 11, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting successful competition in an open market procurement. The award is scheduled for completion by January 2, 2026, with...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a $2,438.82 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency Medical Supply Chain on December 10, 2025, for ultimate completion by December 11, 2025. This delivery order, designated as contract M5, carries no set-aside restrictions and represents an open market procurement. The award funds the supply of...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., received a delivery order award valued at $8,138.78 from the Defense Logistics Agency Medical Supply Chain on December 10, 2025, with an ultimate completion date of January 2, 2026. This fixed-price delivery order with economic price adjustment pricing will be fulfilled at Nuvasive's San Diego facility and involves the supply of LEVERAGE LFS spinal medical devices and related surgical...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order (Contract No. 4570300073) valued at $2,009.60 by the Defense Logistics Agency Medical Supply Chain on December 12, 2025. The contract covers the delivery of MAXCESS spinal surgical products and related medical devices to support Department of Defense and Department of Veterans Affairs healthcare operations. Structured as a firm...
- Nuvasive, Inc., a San Diego-based medical device manufacturer, was awarded a delivery order valued at $1,956.60 by the Defense Logistics Agency Medical Supply Chain on November 28, 2025, with an ultimate completion date of January 5, 2026. This fixed-price delivery order with economic price adjustment mechanism is for MAXCESS spinal surgical products and related medical technologies. The award was issued under an open market competitive procurement with no set-aside designation, reflecting...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $21,266.40 by the Defense Logistics Agency (DLA) Medical Supply Chain on December 10, 2025. This firm fixed-price delivery order with economic price adjustment mechanisms is scheduled for completion by December 31, 2025, and will be performed at Nuvasive's San Diego facility. The contract carries no set-aside designation, reflecting Nuvasive's...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $4,346 fixed-price delivery order with economic price adjustment (FPEA) by the Defense Logistics Agency (DLA) Medical Supply Chain on November 26, 2025, with a completion date of January 5, 2026. This delivery order, issued without set-aside designation, represents a competitive open-market procurement for specialized spinal surgical products and services to support...
- This delivery order, awarded on November 24, 2025, provides for the supply of Small Interlock II spinal implant products to support the medical needs of the Department of Defense and Department of Veterans Affairs. Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in advanced spinal surgery products, received this $10,273.52 fixed-price delivery order with economic price adjustment provisions. The contract is not designated as a set-aside and represents performance at...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order valued at $1,956.60 on December 12, 2025, by the Defense Logistics Agency Medical Supply Chain. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by January 6, 2026, and involves the supply of MAXCESS spinal surgical products and related medical devices to support federal...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F82K6Delivery Order
This delivery order, awarded on December 31, 2025, to Nuvasive, Inc., provides medical devices and surgical products to the Defense Logistics Agency Medical Supply Chain, a defense-focused procurement function serving the Department of Defense and Department of Veterans Affairs healthcare systems. The $3,380.34 fixed-price delivery order with economic price adjustment mechanisms is scheduled for completion by January 2, 2026, and will be performed at Nuvasive's facility in San Diego, California. The award utilizes no set-aside designation, indicating open competition among qualified vendors. Nuvasive, a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., specializes in advanced spinal surgery products including fusion devices, interbody implants, bone graft materials, and surgical instrumentation. This delivery order likely draws against the existing $8 million Blanket Purchase Agreement indefinite delivery/indefinite quantity contract vehicle between Transplant Technology Inc. and the Defense Health Agency, effective through March 2027, which streamlines procurement of Nuvasive's comprehensive spinal technology portfolio across federal healthcare facilities. The company has demonstrated sustained capability as a critical supplier to military and veteran healthcare systems, with prior contract awards ranging from approximately $100 to $71,000 per delivery order. The fixed-price structure with economic price adjustment provisions allows the government to maintain cost certainty while accommodating economic fluctuations inherent in specialized medical device procurement supporting advanced surgical missions across the Department of Defense and Veterans Health Administration networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 12/30/25 |